Skip to content
Screener

Gilead Sciences GILD Asset turnover

Asset turnover at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Incyte logo
IncyteINCY
0.8×0.0×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
0.3×+0.2×
Precigen logo
PrecigenPGEN
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
0.6×+0.3×
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
0.3×+0.1×

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$161.66B+13.5%
Enterprise value$176.21B+8.6%
P/E17.5×-5.0×
P/S5.4×+0.5×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Calculated from Gilead Sciences’s reported figures.

Based on trailing twelve months.

The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 5:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000882095-26-000024

FAQ

What is Gilead Sciences's asset turnover?
Gilead Sciences (GILD) reported asset turnover of 0.5× in Q1 2026.
How has Gilead Sciences's asset turnover changed year-over-year?
Gilead Sciences's asset turnover increased by 3.5% year-over-year, from 0.5× to 0.5×.
What is the long-term trend for Gilead Sciences's asset turnover?
Over 5 years (2020 to 2025), Gilead Sciences's asset turnover has grown at a 5.6% compound annual growth rate (CAGR), from 0.4× to 0.5×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Gilead Sciences's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude